These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25750703)

  • 1. Antiviral Drug- and Multidrug Resistance in Cytomegalovirus Infected SCT Patients.
    Göhring K; Hamprecht K; Jahn G
    Comput Struct Biotechnol J; 2015; 13():153-9. PubMed ID: 25750703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of coexisting HCMV-UL97 and UL54 drug-resistance associated mutations in patients after haematopoietic cell transplantation.
    Göhring K; Wolf D; Bethge W; Mikeler E; Faul C; Vogel W; Vöhringer MC; Jahn G; Hamprecht K
    J Clin Virol; 2013 May; 57(1):43-9. PubMed ID: 23375740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance.
    Fischer L; Imrich E; Sampaio KL; Hofmann J; Jahn G; Hamprecht K; Göhring K
    Antiviral Res; 2016 Jul; 131():1-8. PubMed ID: 27058773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of newly detected, drug-related HCMV UL97- and UL54-mutations using a modified plaque reduction assay.
    Fischer L; Sampaio KL; Jahn G; Hamprecht K; Göhring K
    J Clin Virol; 2015 Aug; 69():150-5. PubMed ID: 26209398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: A retrospective study.
    Campos AB; Ribeiro J; Pinho Vaz C; Campilho F; Branca R; Campos A; Baldaque I; Medeiros R; Boutolleau D; Sousa H
    Antiviral Res; 2017 Feb; 138():86-92. PubMed ID: 27887982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and characterization of a GCV resistant HCMV UL97-mutation and a drug sensitive UL54-mutation.
    Fischer L; Laib Sampaio K; Jahn G; Hamprecht K; Göhring K
    Antiviral Res; 2013 Dec; 100(3):575-7. PubMed ID: 24120366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid detection by reverse hybridization of mutations in the UL97 gene of human cytomegalovirus conferring resistance to ganciclovir.
    Zhou L; Harder TC; Ullmann U; Rautenberg P
    J Clin Virol; 1999 Jun; 13(1-2):53-9. PubMed ID: 10405892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS.
    Baldanti F; Underwood MR; Stanat SC; Biron KK; Chou S; Sarasini A; Silini E; Gerna G
    J Virol; 1996 Mar; 70(3):1390-5. PubMed ID: 8627655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity.
    Mousavi-Jazi M; Schloss L; Drew WL; Linde A; Miner RC; Harmenberg J; Wahren B; Brytting M
    J Clin Virol; 2001 Dec; 23(1-2):1-15. PubMed ID: 11595579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of mixed HCMV UL97 wildtype and mutant strains on ganciclovir susceptibility in a cell associated plaque reduction assay.
    Eckle T; Jahn G; Hamprecht K
    J Clin Virol; 2004 May; 30(1):50-6. PubMed ID: 15072754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganciclovir resistance mutations in UL97 and UL54 genes of Human cytomegalovirus isolates resistant to ganciclovir.
    Foulongne V; Turrière C; Diafouka F; Abraham B; Lastere S; Segondy M
    Acta Virol; 2004; 48(1):51-5. PubMed ID: 15230476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus drug resistance mutations in transplant recipients with suspected resistance.
    Recio V; González I; Tarragó D
    Virol J; 2023 Jul; 20(1):153. PubMed ID: 37464399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations.
    Scott GM; Isaacs MA; Zeng F; Kesson AM; Rawlinson WD
    J Med Virol; 2004 Sep; 74(1):85-93. PubMed ID: 15258973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
    Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C
    J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of drug-resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplant recipients: a prospective monitoring of UL97 and UL54 gene mutations.
    Choi SH; Hwang JY; Park KS; Kim Y; Lee SH; Yoo KH; Kang ES; Ahn JH; Sung KW; Koo HH; Kim YJ
    Transpl Infect Dis; 2014 Dec; 16(6):919-29. PubMed ID: 25405808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mutations in the
    Demin MV; Tikhomirov DS; Biderman BV; Drokov MY; Sudarikov AB; Tupoleva TA; Filatov FP
    Vopr Virusol; 2022 Mar; 67(1):37-47. PubMed ID: 35293187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art.
    Campos AB; Ribeiro J; Boutolleau D; Sousa H
    Rev Med Virol; 2016 May; 26(3):161-82. PubMed ID: 26990717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
    Oshima K; Kanda Y; Kako S; Asano-Mori Y; Watanabe T; Motokura T; Chiba S; Shiraki K; Kurokawa M
    J Med Virol; 2008 Oct; 80(10):1769-75. PubMed ID: 18712833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-host diversity of drug-resistant cytomegalovirus: A case report of cytomegalovirus infection after allogeneic hematopoietic cell transplantation.
    Jung JY; Nho D; Cho SY; Lee DG; Choi SM; Kim HJ; Kim M; Oh EJ
    J Infect Chemother; 2022 Oct; 28(10):1415-1418. PubMed ID: 35810104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood.
    Baldanti F; Simoncini L; Sarasini A; Zavattoni M; Grossi P; Revello MG; Gerna G
    Transplantation; 1998 Aug; 66(3):324-9. PubMed ID: 9721800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.